Targeting Class A and C Serine β-Lactamases with a Broad-Spectrum Boronic Acid Derivative
Citations Over TimeTop 20% of 2014 papers
Abstract
Production of β-lactamases (BLs) is the most widespread resistance mechanism adopted by bacteria to fight β-lactam antibiotics. The substrate spectrum of BLs has become increasingly broad, posing a serious health problem. Thus, there is an urgent need for novel BL inhibitors. Boronic acid transition-state analogues are able to reverse the resistance conferred by class A and C BLs. We describe a boronic acid analogue possessing interesting and potent broad-spectrum activity vs class A and C serine-based BLs. Starting from benzo(b)thiophene-2-boronic acid (BZBTH2B), a nanomolar non-β-lactam inhibitor of AmpC that can potentiate the activity of a third-generation cephalosporin against AmpC-producing resistant bacteria, we designed a novel broad-spectrum nanomolar inhibitor of class A and C BLs. Structure-based drug design (SBDD), synthesis, enzymology data, and X-ray crystallography results are discussed. We clarified the inhibitor binding geometry responsible for broad-spectrum activity vs serine-active BLs using double mutant thermodynamic cycle studies.
Related Papers
- → Boronic Acid-Based Sensors(2002)256 cited
- → One saccharide sensor based on the complex of the boronic acid and the monosaccharide using electrochemical impedance spectroscopy(2005)55 cited
- → The Novel Symbiotic Phenotype of Enhanced-Nodulating Mutant of Lotus japonicus: astray Mutant is an Early Nodulating Mutant with Wider Nodulation Zone(2002)60 cited
- → Studies on a Temperature-sensitive Irreparable Mutant of <i>Neurospora Crassa</i>(1960)11 cited
- → Going beyond Glucose Sensing with Boronic Acid Receptors(2012)8 cited